Global Infectious Bursal Disease Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 109

Published Date: 10 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Infectious Bursal Disease Vaccine is used to prevent infectious bursal disease in chickens, which is one of the main infectious diseases in the chicken industry.

According to our (Global Info Research) latest study, the global Infectious Bursal Disease Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Infectious Bursal Disease Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Infectious Bursal Disease Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Infectious Bursal Disease Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Infectious Bursal Disease Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Infectious Bursal Disease Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Infectious Bursal Disease Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Infectious Bursal Disease Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Merck, Elanco, Boehringer Ingelheim and Ceva, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Infectious Bursal Disease Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Live
    Inactivated

Market segment by Application
    Veterinary Pharmacy
    Online Sale
    Others

Major players covered
    Zoetis
    Merck
    Elanco
    Boehringer Ingelheim
    Ceva
    Qingdao Yibang Biological Engineering Co., Ltd.
    Shandong Lvdu Biological Technology Co., Ltd.
    Plyco Bioengineering Co., Ltd.
    Ruipu Biopharmaceutical Co., Ltd.
    Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Infectious Bursal Disease Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Infectious Bursal Disease Vaccine, with price, sales, revenue and global market share of Infectious Bursal Disease Vaccine from 2018 to 2023.
Chapter 3, the Infectious Bursal Disease Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Infectious Bursal Disease Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Infectious Bursal Disease Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Infectious Bursal Disease Vaccine.
Chapter 14 and 15, to describe Infectious Bursal Disease Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Infectious Bursal Disease Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Infectious Bursal Disease Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Live
        1.3.3 Inactivated
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Infectious Bursal Disease Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Veterinary Pharmacy
        1.4.3 Online Sale
        1.4.4 Others
    1.5 Global Infectious Bursal Disease Vaccine Market Size & Forecast
        1.5.1 Global Infectious Bursal Disease Vaccine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Infectious Bursal Disease Vaccine Sales Quantity (2018-2029)
        1.5.3 Global Infectious Bursal Disease Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Zoetis
        2.1.1 Zoetis Details
        2.1.2 Zoetis Major Business
        2.1.3 Zoetis Infectious Bursal Disease Vaccine Product and Services
        2.1.4 Zoetis Infectious Bursal Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Zoetis Recent Developments/Updates
    2.2 Merck
        2.2.1 Merck Details
        2.2.2 Merck Major Business
        2.2.3 Merck Infectious Bursal Disease Vaccine Product and Services
        2.2.4 Merck Infectious Bursal Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Merck Recent Developments/Updates
    2.3 Elanco
        2.3.1 Elanco Details
        2.3.2 Elanco Major Business
        2.3.3 Elanco Infectious Bursal Disease Vaccine Product and Services
        2.3.4 Elanco Infectious Bursal Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Elanco Recent Developments/Updates
    2.4 Boehringer Ingelheim
        2.4.1 Boehringer Ingelheim Details
        2.4.2 Boehringer Ingelheim Major Business
        2.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Product and Services
        2.4.4 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Boehringer Ingelheim Recent Developments/Updates
    2.5 Ceva
        2.5.1 Ceva Details
        2.5.2 Ceva Major Business
        2.5.3 Ceva Infectious Bursal Disease Vaccine Product and Services
        2.5.4 Ceva Infectious Bursal Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Ceva Recent Developments/Updates
    2.6 Qingdao Yibang Biological Engineering Co., Ltd.
        2.6.1 Qingdao Yibang Biological Engineering Co., Ltd. Details
        2.6.2 Qingdao Yibang Biological Engineering Co., Ltd. Major Business
        2.6.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
        2.6.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments/Updates
    2.7 Shandong Lvdu Biological Technology Co., Ltd.
        2.7.1 Shandong Lvdu Biological Technology Co., Ltd. Details
        2.7.2 Shandong Lvdu Biological Technology Co., Ltd. Major Business
        2.7.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
        2.7.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Shandong Lvdu Biological Technology Co., Ltd. Recent Developments/Updates
    2.8 Plyco Bioengineering Co., Ltd.
        2.8.1 Plyco Bioengineering Co., Ltd. Details
        2.8.2 Plyco Bioengineering Co., Ltd. Major Business
        2.8.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
        2.8.4 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Plyco Bioengineering Co., Ltd. Recent Developments/Updates
    2.9 Ruipu Biopharmaceutical Co., Ltd.
        2.9.1 Ruipu Biopharmaceutical Co., Ltd. Details
        2.9.2 Ruipu Biopharmaceutical Co., Ltd. Major Business
        2.9.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
        2.9.4 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments/Updates
    2.10 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
        2.10.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Details
        2.10.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Major Business
        2.10.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
        2.10.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments/Updates

3 Competitive Environment: Infectious Bursal Disease Vaccine by Manufacturer
    3.1 Global Infectious Bursal Disease Vaccine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Infectious Bursal Disease Vaccine Revenue by Manufacturer (2018-2023)
    3.3 Global Infectious Bursal Disease Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Infectious Bursal Disease Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Infectious Bursal Disease Vaccine Manufacturer Market Share in 2022
        3.4.2 Top 6 Infectious Bursal Disease Vaccine Manufacturer Market Share in 2022
    3.5 Infectious Bursal Disease Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Infectious Bursal Disease Vaccine Market: Region Footprint
        3.5.2 Infectious Bursal Disease Vaccine Market: Company Product Type Footprint
        3.5.3 Infectious Bursal Disease Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Infectious Bursal Disease Vaccine Market Size by Region
        4.1.1 Global Infectious Bursal Disease Vaccine Sales Quantity by Region (2018-2029)
        4.1.2 Global Infectious Bursal Disease Vaccine Consumption Value by Region (2018-2029)
        4.1.3 Global Infectious Bursal Disease Vaccine Average Price by Region (2018-2029)
    4.2 North America Infectious Bursal Disease Vaccine Consumption Value (2018-2029)
    4.3 Europe Infectious Bursal Disease Vaccine Consumption Value (2018-2029)
    4.4 Asia-Pacific Infectious Bursal Disease Vaccine Consumption Value (2018-2029)
    4.5 South America Infectious Bursal Disease Vaccine Consumption Value (2018-2029)
    4.6 Middle East and Africa Infectious Bursal Disease Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Infectious Bursal Disease Vaccine Sales Quantity by Type (2018-2029)
    5.2 Global Infectious Bursal Disease Vaccine Consumption Value by Type (2018-2029)
    5.3 Global Infectious Bursal Disease Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Infectious Bursal Disease Vaccine Sales Quantity by Application (2018-2029)
    6.2 Global Infectious Bursal Disease Vaccine Consumption Value by Application (2018-2029)
    6.3 Global Infectious Bursal Disease Vaccine Average Price by Application (2018-2029)

7 North America
    7.1 North America Infectious Bursal Disease Vaccine Sales Quantity by Type (2018-2029)
    7.2 North America Infectious Bursal Disease Vaccine Sales Quantity by Application (2018-2029)
    7.3 North America Infectious Bursal Disease Vaccine Market Size by Country
        7.3.1 North America Infectious Bursal Disease Vaccine Sales Quantity by Country (2018-2029)
        7.3.2 North America Infectious Bursal Disease Vaccine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Infectious Bursal Disease Vaccine Sales Quantity by Type (2018-2029)
    8.2 Europe Infectious Bursal Disease Vaccine Sales Quantity by Application (2018-2029)
    8.3 Europe Infectious Bursal Disease Vaccine Market Size by Country
        8.3.1 Europe Infectious Bursal Disease Vaccine Sales Quantity by Country (2018-2029)
        8.3.2 Europe Infectious Bursal Disease Vaccine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Infectious Bursal Disease Vaccine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Infectious Bursal Disease Vaccine Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Infectious Bursal Disease Vaccine Market Size by Region
        9.3.1 Asia-Pacific Infectious Bursal Disease Vaccine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Infectious Bursal Disease Vaccine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Infectious Bursal Disease Vaccine Sales Quantity by Type (2018-2029)
    10.2 South America Infectious Bursal Disease Vaccine Sales Quantity by Application (2018-2029)
    10.3 South America Infectious Bursal Disease Vaccine Market Size by Country
        10.3.1 South America Infectious Bursal Disease Vaccine Sales Quantity by Country (2018-2029)
        10.3.2 South America Infectious Bursal Disease Vaccine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Infectious Bursal Disease Vaccine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Infectious Bursal Disease Vaccine Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Infectious Bursal Disease Vaccine Market Size by Country
        11.3.1 Middle East & Africa Infectious Bursal Disease Vaccine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Infectious Bursal Disease Vaccine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Infectious Bursal Disease Vaccine Market Drivers
    12.2 Infectious Bursal Disease Vaccine Market Restraints
    12.3 Infectious Bursal Disease Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Infectious Bursal Disease Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Infectious Bursal Disease Vaccine
    13.3 Infectious Bursal Disease Vaccine Production Process
    13.4 Infectious Bursal Disease Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Infectious Bursal Disease Vaccine Typical Distributors
    14.3 Infectious Bursal Disease Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Infectious Bursal Disease Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Infectious Bursal Disease Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Zoetis Basic Information, Manufacturing Base and Competitors
    Table 4. Zoetis Major Business
    Table 5. Zoetis Infectious Bursal Disease Vaccine Product and Services
    Table 6. Zoetis Infectious Bursal Disease Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Zoetis Recent Developments/Updates
    Table 8. Merck Basic Information, Manufacturing Base and Competitors
    Table 9. Merck Major Business
    Table 10. Merck Infectious Bursal Disease Vaccine Product and Services
    Table 11. Merck Infectious Bursal Disease Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Merck Recent Developments/Updates
    Table 13. Elanco Basic Information, Manufacturing Base and Competitors
    Table 14. Elanco Major Business
    Table 15. Elanco Infectious Bursal Disease Vaccine Product and Services
    Table 16. Elanco Infectious Bursal Disease Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Elanco Recent Developments/Updates
    Table 18. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 19. Boehringer Ingelheim Major Business
    Table 20. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product and Services
    Table 21. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Boehringer Ingelheim Recent Developments/Updates
    Table 23. Ceva Basic Information, Manufacturing Base and Competitors
    Table 24. Ceva Major Business
    Table 25. Ceva Infectious Bursal Disease Vaccine Product and Services
    Table 26. Ceva Infectious Bursal Disease Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Ceva Recent Developments/Updates
    Table 28. Qingdao Yibang Biological Engineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 29. Qingdao Yibang Biological Engineering Co., Ltd. Major Business
    Table 30. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
    Table 31. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments/Updates
    Table 33. Shandong Lvdu Biological Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 34. Shandong Lvdu Biological Technology Co., Ltd. Major Business
    Table 35. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
    Table 36. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Shandong Lvdu Biological Technology Co., Ltd. Recent Developments/Updates
    Table 38. Plyco Bioengineering Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 39. Plyco Bioengineering Co., Ltd. Major Business
    Table 40. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
    Table 41. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Plyco Bioengineering Co., Ltd. Recent Developments/Updates
    Table 43. Ruipu Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 44. Ruipu Biopharmaceutical Co., Ltd. Major Business
    Table 45. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
    Table 46. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Ruipu Biopharmaceutical Co., Ltd. Recent Developments/Updates
    Table 48. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 49. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Major Business
    Table 50. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product and Services
    Table 51. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Recent Developments/Updates
    Table 53. Global Infectious Bursal Disease Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 54. Global Infectious Bursal Disease Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 55. Global Infectious Bursal Disease Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 56. Market Position of Manufacturers in Infectious Bursal Disease Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 57. Head Office and Infectious Bursal Disease Vaccine Production Site of Key Manufacturer
    Table 58. Infectious Bursal Disease Vaccine Market: Company Product Type Footprint
    Table 59. Infectious Bursal Disease Vaccine Market: Company Product Application Footprint
    Table 60. Infectious Bursal Disease Vaccine New Market Entrants and Barriers to Market Entry
    Table 61. Infectious Bursal Disease Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 62. Global Infectious Bursal Disease Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 63. Global Infectious Bursal Disease Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 64. Global Infectious Bursal Disease Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 65. Global Infectious Bursal Disease Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 66. Global Infectious Bursal Disease Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 67. Global Infectious Bursal Disease Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 68. Global Infectious Bursal Disease Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 69. Global Infectious Bursal Disease Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 70. Global Infectious Bursal Disease Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 71. Global Infectious Bursal Disease Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 72. Global Infectious Bursal Disease Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 73. Global Infectious Bursal Disease Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 74. Global Infectious Bursal Disease Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 75. Global Infectious Bursal Disease Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 76. Global Infectious Bursal Disease Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 77. Global Infectious Bursal Disease Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 78. Global Infectious Bursal Disease Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 79. Global Infectious Bursal Disease Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 80. North America Infectious Bursal Disease Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 81. North America Infectious Bursal Disease Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 82. North America Infectious Bursal Disease Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 83. North America Infectious Bursal Disease Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 84. North America Infectious Bursal Disease Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 85. North America Infectious Bursal Disease Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 86. North America Infectious Bursal Disease Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 87. North America Infectious Bursal Disease Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 88. Europe Infectious Bursal Disease Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 89. Europe Infectious Bursal Disease Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 90. Europe Infectious Bursal Disease Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 91. Europe Infectious Bursal Disease Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 92. Europe Infectious Bursal Disease Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 93. Europe Infectious Bursal Disease Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 94. Europe Infectious Bursal Disease Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 95. Europe Infectious Bursal Disease Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 96. Asia-Pacific Infectious Bursal Disease Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 97. Asia-Pacific Infectious Bursal Disease Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 98. Asia-Pacific Infectious Bursal Disease Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 99. Asia-Pacific Infectious Bursal Disease Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 100. Asia-Pacific Infectious Bursal Disease Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 101. Asia-Pacific Infectious Bursal Disease Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 102. Asia-Pacific Infectious Bursal Disease Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 103. Asia-Pacific Infectious Bursal Disease Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 104. South America Infectious Bursal Disease Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 105. South America Infectious Bursal Disease Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 106. South America Infectious Bursal Disease Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 107. South America Infectious Bursal Disease Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 108. South America Infectious Bursal Disease Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 109. South America Infectious Bursal Disease Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 110. South America Infectious Bursal Disease Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 111. South America Infectious Bursal Disease Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 112. Middle East & Africa Infectious Bursal Disease Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 113. Middle East & Africa Infectious Bursal Disease Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 114. Middle East & Africa Infectious Bursal Disease Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 115. Middle East & Africa Infectious Bursal Disease Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 116. Middle East & Africa Infectious Bursal Disease Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 117. Middle East & Africa Infectious Bursal Disease Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 118. Middle East & Africa Infectious Bursal Disease Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 119. Middle East & Africa Infectious Bursal Disease Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 120. Infectious Bursal Disease Vaccine Raw Material
    Table 121. Key Manufacturers of Infectious Bursal Disease Vaccine Raw Materials
    Table 122. Infectious Bursal Disease Vaccine Typical Distributors
    Table 123. Infectious Bursal Disease Vaccine Typical Customers
List of Figures
    Figure 1. Infectious Bursal Disease Vaccine Picture
    Figure 2. Global Infectious Bursal Disease Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Infectious Bursal Disease Vaccine Consumption Value Market Share by Type in 2022
    Figure 4. Live Examples
    Figure 5. Inactivated Examples
    Figure 6. Global Infectious Bursal Disease Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Infectious Bursal Disease Vaccine Consumption Value Market Share by Application in 2022
    Figure 8. Veterinary Pharmacy Examples
    Figure 9. Online Sale Examples
    Figure 10. Others Examples
    Figure 11. Global Infectious Bursal Disease Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Infectious Bursal Disease Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Infectious Bursal Disease Vaccine Sales Quantity (2018-2029) & (K Units)
    Figure 14. Global Infectious Bursal Disease Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 15. Global Infectious Bursal Disease Vaccine Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Infectious Bursal Disease Vaccine Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Infectious Bursal Disease Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Infectious Bursal Disease Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Infectious Bursal Disease Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Infectious Bursal Disease Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Infectious Bursal Disease Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Infectious Bursal Disease Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Infectious Bursal Disease Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Infectious Bursal Disease Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Infectious Bursal Disease Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Infectious Bursal Disease Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Infectious Bursal Disease Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Infectious Bursal Disease Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Infectious Bursal Disease Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 30. Global Infectious Bursal Disease Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Infectious Bursal Disease Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Infectious Bursal Disease Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 33. North America Infectious Bursal Disease Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Infectious Bursal Disease Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Infectious Bursal Disease Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Infectious Bursal Disease Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Infectious Bursal Disease Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Infectious Bursal Disease Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Infectious Bursal Disease Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Infectious Bursal Disease Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Infectious Bursal Disease Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Infectious Bursal Disease Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Infectious Bursal Disease Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Infectious Bursal Disease Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Infectious Bursal Disease Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Infectious Bursal Disease Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Infectious Bursal Disease Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Infectious Bursal Disease Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Infectious Bursal Disease Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Infectious Bursal Disease Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Infectious Bursal Disease Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Infectious Bursal Disease Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Infectious Bursal Disease Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Infectious Bursal Disease Vaccine Market Drivers
    Figure 74. Infectious Bursal Disease Vaccine Market Restraints
    Figure 75. Infectious Bursal Disease Vaccine Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Infectious Bursal Disease Vaccine in 2022
    Figure 78. Manufacturing Process Analysis of Infectious Bursal Disease Vaccine
    Figure 79. Infectious Bursal Disease Vaccine Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Zoetis
Merck
Elanco
Boehringer Ingelheim
Ceva
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Plyco Bioengineering Co., Ltd.
Ruipu Biopharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.

Related Reports

Global Infectious Bursal Disease Vaccine Supply, Demand and Key Producers, 2023-2029

Global Infectious Bursal Disease Vaccine Supply, Demand and Key Producers, 2023-2029

date 03 Feb 2023

date Pharma & Healthcare

The global Infectious Bursal Disease Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Infectious Bursal Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Infectious Bursal Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Infectious Bursal Disease Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Infectious Bursal Disease Vaccine Supply, Demand and Key Producers, 2024-2030

Global Infectious Bursal Disease Vaccine Supply, Demand and Key Producers, 2024-2030

date 03 Mar 2024

date Pharma & Healthcare

The global Infectious Bursal Disease Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Newcastle Disease, Infectious Bronchitis and Infectious Bursal Disease Vaccine

Infectious Bursal Disease Vaccine

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>